Research & Development
Risk begins well before a product reaches market. Intellectual property, cybersecurity, clinical trials, research assets and supply chain uncertainty can affect progress at every stage of development.
HUB’s Life Sciences specialists help R&D organizations identify and manage risk across the development lifecycle, from prototyping and field testing through clinical trials, regulatory submission and commercialization.
Stay Ahead of Industry Challenges
As the science advances, the risk profile changes
R&D organizations can move from early research and prototyping into clinical trials, regulatory submissions and preparation for commercialization. Each milestone can introduce new exposures, making it important for the risk strategy to evolve alongside the development program.
Clinical trial sponsors can face liability arising from participant injury and other trial-related events while a product’s safety and performance profile is still being established. Requirements can become more complex when studies extend across multiple jurisdictions.
HUB structures clinical trial liability around the study, participant population, trial locations and applicable insurance requirements, with international coordination where required.
Clinical trial coverage should reflect the study being conducted, the participants involved and where the trial takes place.
Trial protection aligned with the research program and geographic footprint.
R&D organizations depend on intellectual property, scientific data, specialized equipment and digital systems well before they have a commercial product. A cyber event, equipment failure, research interruption or loss involving these assets can disrupt development and put valuable work at risk.
HUB evaluates intellectual property risk, cyber, property and equipment exposures against the organization’s research activities and critical dependencies.
Before commercialization, protecting the research itself is central to protecting the organization’s progress.
Protection focused on the assets and systems required to keep development moving.
As organizations move from research and prototyping into trials, regulatory submissions and commercialization, their exposures can expand across facilities, contracts, suppliers, people and eventually product liability.
HUB takes a lifecycle view of the risk program, helping organizations assess how coverage and risk management should evolve as scientific activities, operations and commercial plans change.
The right program for laboratory research may not be the right program for clinical trials or commercialization.
A risk strategy designed to evolve alongside the development program.
Tailored Risk Solutions for Your Industry
Build protection around the development lifecycle
R&D organizations do not carry the same risks at every stage of development. HUB considers the research being conducted, clinical activity, critical assets, third-party relationships and plans for growth together to help build a program that can evolve as the science advances.
Clinical trial liability can be structured around the study, participants and locations involved. Property and equipment coverage can help protect specialized laboratory and research assets, while cyber protection can address sensitive research data and digital dependencies.
HUB considers intellectual property protection, contractual risk transfer, research partnerships, suppliers and other third-party relationships as part of the broader risk profile. These exposures can change as development advances and external partnerships expand.
As R&D organizations grow, new funding, workforce and commercial requirements can change the risk profile. Management liability and other commercial protections can evolve alongside the organization, while employee benefits can support the attraction and retention of specialized scientific and technical talent.
Industry Insights
Insights and resources for Life Sciences R&D organizations
